A groundbreaking clinical trial focused on improving sleep health among older adults is set to commence. Sponsored by Proactive Life Inc. and the National Institute on Aging (NIA), this study will evaluate the safety and efficacy of advanced interventions such as AI-based Cognitive Behavioral Therapy for Insomnia (CBT-I). Clinical trials targeting insomnia are crucial, as sleep is vital to healthy aging.
What changed?
The trial introduces three distinct behavioral interventions for insomnia management. These include:
- CBT-I-IoT-AI: A novel therapy utilizing artificial intelligence combined with the Internet of Things (IoT) to deliver personalized cognitive behavioral therapy.
- SleepEZ CBTi: A digital platform providing evidence-based CBT for insomnia tailored to user profiles.
- Sleep Hygiene IoT: An intervention focusing on improving sleep environments through IoT technologies.
Although the trial is not yet recruiting participants, its advanced focus on integrating technology into behavioral therapies positions it as a notable development in medical device-assisted treatments.
How will the study be conducted?
The trial will operate under stringent regulatory oversight, ensuring compliance with medical device safety and performance standards. Eligible participants will include older adults who are diagnosed with insomnia or chronic insomnia.
The interventions will be assessed for their ability to enhance sleep quality using objective measures such as sleep latency, duration, and efficiency. At each phase of the trial, participant safety and the reliability of device-based behavioral therapies will be monitored consistently. This format aligns with MDR Annex XIV requirements to demonstrate clinical evidence and intended use effectively.
Who is conducting the study?
The study is sponsored by Proactive Life Inc., in collaboration with NIA. Both organizations have a track record of pursuing innovative, evidence-based health solutions for aging populations.
What are the expected outcomes?
The primary aim of this trial is to determine whether these AI-based and IoT-enhanced CBT treatments significantly improve sleep outcomes among older adults. Secondary objectives include assessing patient adherence to technology-assisted therapies and their long-term impact on psychological well-being.
Should the trial yield positive results, it may pave the way for regulatory approvals and broader adoption of these solutions globally. Insomnia significantly impacts public health costs and quality of life, and technologies enabling safe, validated interventions represent a milestone in clinical care.
FAQs
1. Who should participate in this trial?
Older adults diagnosed with insomnia or chronic insomnia may be eligible to participate. Recruitment details will be announced soon.
2. What makes these interventions unique?
The interventions uniquely integrate AI and IoT technology into traditional CBT for insomnia, enabling personalized and measurable solutions.
3. Where can I learn more details?
Full details can be accessed on the ClinicalTrials.gov listing.
Conclusion
This upcoming clinical trial highlights a significant stride in the development of AI-powered solutions for health issues commonly faced by aging populations. Stakeholders in medical innovation and clinical research are encouraged to follow its progress to stay informed on virtual and device-assisted advancements in sleep therapy.
Disclaimer
This article is for informational purposes only and does not constitute legal or medical advice. Always consult relevant professionals for guidance specific to your needs.
Further information
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07316153?term=medical+device